Syncom Formulations: MD appointed, family board changes confirmed at AGM
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.0 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syncom Formulations shareholders at the 38th AGM on Sept 30, 2026 confirmed three board changes: (1) Rahul Vijay Bankda, from the promoter group and son of the past Managing Director, appointed as Managing Director effective Aug 12, 2026; (2) Rinki Ankit Bankda, spouse of current Chairman Ankit Kedarmal Bankda, appointed as Whole Time Director effective Aug 12, 2026; (3) Ruchi Jindal reappointed as Woman Independent Director for a second five-year term from June 28, 2027 to June 27, 2032.
Promoter family tightens control with two new executive director seats; boosts continuity but increases related-party board concentration.